Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G while Breastfeeding
Breast milk is superior in nutrition, It provides resistance against infections and allergies, It is naturally sterile. Despite all the advantages of breastfeeding some mothers choose to pause the breastfeeding in fear of harmful effects of medicines passing in breast milk. Are you wondering about breastfeeding and using Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G ? Know what is Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G and how it can affect your breast milk and whether Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G is safe for your kid or not.

What is Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G ?


helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Brief: Active ingredients Purpose OCTINOXATE 1.9% Sunscreen TITANUIM DIOXIDE 4.1% Sunscreen

Can I use Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G while breastfeeding?

Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G high risk while breastfeeding
Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G consists two active ingredients Octinoxate and Titanium dioxide and as per our analysis of both we have determined the Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G is unsafe during breastfeeding. We recommend you to check both ingredients below for better understanding of Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G in breastfeeding.

Octinoxate and Breastfeeding

Unsafe

Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G and breastfeeding

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (5001000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.

Is Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G safe while breastfeeding

What if I already have used Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G?

We have already established that Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G is unsafe in breastfeeding and breastfeeding while using Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


My doctor has prescribed me Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G then there must be good reason for that as Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Cle De Peau Beaute Silky Foundation I Bf20 | Octinoxate 539 Mg, Titanium Dioxide 1.16 G in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week